CVRdatabase
Menu

Inprother ApS

Private limited companyCVR 33968426FrederiksbergActive

Inprother ApS is a private limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2011. The company made a loss in both 2024 and 2025, most recently DKK 21.2m. With 18 employees, the company is about 4 times larger than the industry median. Equity fell to DKK 31.8m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 12.5m−384.6% vs. 2024
Net profit−DKK 21.2m−146% vs. 2024
EquityDKK 31.8m−58.1% vs. 2024
Employees18latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 8.6m to DKK 21.2m (2024 → 2025).
  • Equity fell 58% (2024 → 2025), to DKK 31.8m.

Employees

  • 1 more employees than a year earlier: 18 (08/2026) against 17 (08/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 40m−DKK 20mDKK 0DKK 20mDKK 40mDKK 60mDKK 80m202020212022202320242025
EquityNet profit
Financial figures for Inprother ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−2,744−1,780−2,138−310−2,587−12,534−384.6%
Operating profit (EBIT)–−5,207−12,424−7,018−11,182−24,893−122.6%
Profit before tax−9,208−5,874−14,346−9,604−12,060−25,583−112.1%
Net profit−6,976−3,739−11,587−7,446−8,622−21,209−146%
Total assets10,32020,63024,46538,276116,78048,517−58.5%
Equity−2,063−5,801−20,422−27,86875,88131,798−58.1%
Liabilities12,38326,43244,88666,14340,90016,719−59.1%
Cash and cash equivalents6,8699,0373504,42665,42838,207−41.6%
Average number of employees12141681012+20%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 14m−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Equity fell sharply

    Equity fell 58% from 2024 to 2025 (DKK 75.9m to DKK 31.8m).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Inprother ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202501/07/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202423/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202330/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202223/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202121/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202022/05/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0510152009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 12.5mNo. 397 of 421
Better than 6% of the companies in the industry
EquityDKK 31.8mNo. 80 of 431
Better than 82% of the companies in the industry
Number of employees18No. 129 of 431
Better than 70% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,665of 69,742
Better than 0%
No. 4,287of 69,964
Better than 94%
Same industry and fewer than 20 employees329 companies in the comparison
No. 312of 323
Better than 3%
No. 24of 329
Better than 93%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 24,754of 24,791
Better than 0%
No. 3,248of 24,909
Better than 87%
All companies of type ApS66,508 companies in the comparison
No. 66,303of 66,379
Better than 0%
No. 3,021of 66,505
Better than 95%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Inprother ApS−DKK 12.5m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Inprother ApS−DKK 21.2m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Inprother ApSDKK 31.8m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Inprother ApS18
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Peter Holst Consulting ApS33.33%
  • Biostrat Biotech Consulting ApS5%
  • EIC Fund20%
  • Serum Institute Of India Private Limited15%
Inprother ApS

Management

5 active registrations

Executive management

Executive management at Inprother ApS
NameRoleAppointed
John Robert M ColemanCEO14/11/2023

Board of directors

Board of directors at Inprother ApS
NameRoleAppointed
Peter Johannes HolstBoard member24/10/2011
Christian Olivier ThirionBoard member24/01/2020
Michael Sven RohmannBoard member26/06/2024
John Robert M ColemanChair of the board26/06/2024
Founders
Nikolaj Juhl Hansen, Peter Holst Consulting ApS
Former management (11)
Former management at Inprother ApS
NameRoleAppointedResigned
Jesper ZeuthenChair of the board24/10/201113/06/2022
Peter Johannes HolstDirector24/10/201130/05/2019
Peter Samuel WulffBoard member10/08/201222/05/2018
Nicolaj Højer NielsenBoard member22/05/201822/06/2023
Mathias KrollCEO01/06/201911/12/2019
Peter Johannes HolstCEO11/12/201906/05/2020
Kim Arvid NielsenCEO06/05/202012/10/2020
Peter Johannes HolstCEO12/10/202012/02/2021
Jordi Naval ChamosaCEO12/02/202131/10/2023
Jesper ZeuthenBoard member14/06/202203/06/2024
Michael Sven RohmannChair of the board14/06/202225/06/2024

Signing rule: Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør.

Address and production units

1 active production units

Nordre Fasanvej 215
2000 Frederiksberg

Frederiksberg Municipality · Postcode 2000

Other companies at the address (8)

  • Sparrow Quantum ApSManufacture of computers and peripheral equipment
  • Adcendo ApSResearch and experimental development on natural sciences and engineering
  • Hemab ApSManufacture of pharmaceutical preparations
  • Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
  • Minervax ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
INPROTHER ApSNordre Fasanvej 215, 2000 Frederiksberg181017213047

Purpose

Selskabets formål er at udvikle immunterapier mod kræft, aldring og neurodegenerative sygdomme som ALS, MS og Alzheimers samt enhver anden virksomhed, som bestyrelsen anser for at være forbundet hermed.

The purpose is quoted from the register in Danish.

Changes year by year

55 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202411 changescapital 3 · address 1 · accounts 1 · management 4 · ownership 2
  • Share capital changed from 229,043 DKK to 229,156 DKK
  • Moved to Nordre Fasanvej 215, 2000 Frederiksberg
  • Annual report for 2023 published
  • John Robert M Coleman appointed chair of the board
  • Michael Sven Rohmann appointed board member
  • Michael Sven Rohmann stepped down as chair of the board
  • Jesper Zeuthen stepped down as board member
  • Share capital changed from 149,134 DKK to 229,043 DKK
  • EIC Fund registered as owner (20%)
  • SERUM INSTITUTE OF INDIA PRIVATE LIMITED registered as owner (15%)
  • Share capital changed from 101,674 DKK to 149,134 DKK
20234 changesmanagement 3 · accounts 1
  • John Robert M Coleman appointed ceo
  • Jordi Naval Chamosa stepped down as ceo
  • Annual report for 2022 published
  • Nicolaj Højer Nielsen stepped down as board member
20224 changesaccounts 1 · management 3
  • Annual report for 2021 published
  • Jesper Zeuthen appointed board member
  • Michael Sven Rohmann appointed chair of the board
  • Jesper Zeuthen stepped down as chair of the board
20213 changesaccounts 1 · management 2
  • Annual report for 2020 published
  • Jordi Naval Chamosa appointed ceo
  • Peter Johannes Holst stepped down as ceo
20209 changesmanagement 5 · capital 2 · ownership 2
  • Peter Johannes Holst appointed ceo
  • Kim Arvid Nielsen stepped down as ceo
  • Share capital changed from 101,673 DKK to 101,674 DKK
  • Kim Arvid Nielsen appointed ceo
  • Peter Johannes Holst stepped down as ceo
  • Share capital changed from 98,763 DKK to 101,673 DKK
  • Christian Olivier Thirion appointed board member
  • BIOSTRAT BIOTECH CONSULTING ApS registered as owner (5%)
  • BIOSTRAT BIOTECH CONSULTING ApS is no longer registered as owner
201910 changesmanagement 4 · capital 2 · ownership 3 · address 1
  • Peter Johannes Holst appointed ceo
  • Mathias Kroll stepped down as ceo
  • Share capital changed from 94,119 DKK to 98,763 DKK
  • Share capital changed from 80,001 DKK to 94,119 DKK
  • BIOSTRAT BIOTECH CONSULTING ApS registered as owner (15%)
  • PETER HOLST CONSULTING ApS registered as owner (33.33%)
  • PETER HOLST CONSULTING ApS is no longer registered as owner
  • Mathias Kroll appointed ceo
  • Peter Johannes Holst stepped down as director
  • Moved to Ole Maaløes Vej 3, 2200 København N
20182 changesmanagement 2
  • Nicolaj Højer Nielsen appointed board member
  • Peter Samuel Wulff stepped down as board member
20161 changeaddress 1
  • Moved to Tolstojs Alle 14, 2860 Søborg
20123 changescapital 1 · management 1 · industry 1
  • Share capital changed from 80,000 DKK to 80,001 DKK
  • Peter Samuel Wulff appointed board member
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20115 changesfounded 1 · management 3 · ownership 1
  • Registered as INPROTHER ApS
  • Peter Johannes Holst appointed director
  • Jesper Zeuthen appointed chair of the board
  • Peter Johannes Holst appointed board member
  • PETER HOLST CONSULTING ApS registered as owner (90%)

Related companies

Same industry in Frederiksberg

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction